ATE236143T1 - Die wirkstoffresistenz in der krebs-chemotherapie umkehrende taxoide mittel und pharmazeutische zubereitungen davon - Google Patents

Die wirkstoffresistenz in der krebs-chemotherapie umkehrende taxoide mittel und pharmazeutische zubereitungen davon

Info

Publication number
ATE236143T1
ATE236143T1 AT97954636T AT97954636T ATE236143T1 AT E236143 T1 ATE236143 T1 AT E236143T1 AT 97954636 T AT97954636 T AT 97954636T AT 97954636 T AT97954636 T AT 97954636T AT E236143 T1 ATE236143 T1 AT E236143T1
Authority
AT
Austria
Prior art keywords
agents
reversing
taxoid
drug resistance
pharmaceutical preparations
Prior art date
Application number
AT97954636T
Other languages
English (en)
Inventor
Iwao Ojima
Ralph J Bernacki
Original Assignee
Univ New York State Res Found
Health Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York State Res Found, Health Research Inc filed Critical Univ New York State Res Found
Application granted granted Critical
Publication of ATE236143T1 publication Critical patent/ATE236143T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT97954636T 1997-01-08 1997-12-29 Die wirkstoffresistenz in der krebs-chemotherapie umkehrende taxoide mittel und pharmazeutische zubereitungen davon ATE236143T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/780,633 US5811452A (en) 1997-01-08 1997-01-08 Taxoid reversal agents for drug-resistance in cancer chemotherapy and pharmaceutical compositions thereof
PCT/US1997/024020 WO1998030553A1 (en) 1997-01-08 1997-12-29 Taxoid reversal agents for drug-resistance in cancer chemotherapy and pharmaceutical compositions thereof

Publications (1)

Publication Number Publication Date
ATE236143T1 true ATE236143T1 (de) 2003-04-15

Family

ID=25120175

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97954636T ATE236143T1 (de) 1997-01-08 1997-12-29 Die wirkstoffresistenz in der krebs-chemotherapie umkehrende taxoide mittel und pharmazeutische zubereitungen davon

Country Status (12)

Country Link
US (1) US5811452A (de)
EP (1) EP0966456B1 (de)
JP (1) JP2001509150A (de)
KR (1) KR20000069887A (de)
AT (1) ATE236143T1 (de)
AU (1) AU738536B2 (de)
BR (1) BR9714272A (de)
CA (1) CA2276483A1 (de)
DE (1) DE69720535T2 (de)
ES (1) ES2196393T3 (de)
IL (1) IL130669A0 (de)
WO (1) WO1998030553A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6005120A (en) 1993-07-20 1999-12-21 Florida State University Tricyclic and tetracyclic taxanes
US7288665B1 (en) * 1997-08-18 2007-10-30 Florida State University Process for selective derivatization of taxanes
US6020507A (en) * 1998-03-02 2000-02-01 Bristol-Myers Squibb Company Synthesis of paclitaxel from baccatin III by protection of the 7-hydroxyl of baccatin III using a strong base and an electrophile
ATE349438T1 (de) * 1999-11-24 2007-01-15 Immunogen Inc Cytotoxische wirkstoffe enthaltend taxane und deren therapeutische anwendung
PL350315A1 (en) 2000-02-02 2002-12-02 Univ Florida State Res Found C7 carbonate substituted taxanes as antitumor agents
BR0104350A (pt) 2000-02-02 2002-01-02 Univ Florida State Res Found Taxanos de c10 acetato heterossubstituìdo como agentes antitumor
PL350328A1 (en) * 2000-02-02 2002-12-02 Univ Florida State Res Found C7 heterosubstituted acetate taxanes as antitumor agents
ATE392422T1 (de) 2000-02-02 2008-05-15 Univ Florida State Res Found C7-carbamoyloxysubstituierte taxane als antitumormittel
JP2003522173A (ja) * 2000-02-02 2003-07-22 フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド 抗腫瘍剤としてのｃ１０カルバモイルオキシ置換タキサン
CA2368151A1 (en) 2000-02-02 2001-08-09 Florida State University Research Foundation, Inc. C10 carbonate substituted taxanes as antitumor agents
US6649632B2 (en) 2000-02-02 2003-11-18 Fsu Research Foundation, Inc. C10 ester substituted taxanes
CO5280224A1 (es) 2000-02-02 2003-05-30 Univ Florida State Res Found Taxanos sustituidos con ester en c7, utiles como agentes antitumorales y composiciones farmaceuticas que los contienen
JP2004508412A (ja) 2000-09-11 2004-03-18 セラプロ　テクノロジーズ　インコーポレーティッド 抗新生物薬および免疫刺激薬としてのチオニン
ITMI20012185A1 (it) * 2001-10-19 2003-04-19 Indena Spa Procedimento per la preparazione della 14beta-idrossi-baccatina iii-1,14-carbonato
ITMI20012186A1 (it) * 2001-10-19 2003-04-19 Indena Spa Procedimento per la preparazione della 14-beta-idrossi-baccatina iii-1,14-carbonato
AU2003256847A1 (en) * 2002-07-26 2004-02-16 Advanced Research And Technology Institute At Indiana University Method of treating cancer
EP1534674A4 (de) 2002-08-02 2007-11-28 Immunogen Inc Zytotoxische mittel, die neue, wirkungsvolle taxane enthalten, und deren therapeutische verwendung
US7390898B2 (en) 2002-08-02 2008-06-24 Immunogen Inc. Cytotoxic agents containing novel potent taxanes and their therapeutic use
ITMI20021921A1 (it) * 2002-09-10 2004-03-11 Indena Spa Funzionalizzazione della posizione 14 dei nuclei tassanici e sintesi di nuovi derivati antitumorali.
EP1562927B1 (de) * 2002-10-09 2009-05-13 Chatham Biotec Ltd. Thio-analoga von paclitaxel und deren vorprodukte
BR0314555A (pt) * 2002-10-11 2005-08-09 Dana Farber Cancer Inst Inc Derivados de epotilona para o tratamento de mieloma múltiplo
US7064980B2 (en) * 2003-09-17 2006-06-20 Sandisk Corporation Non-volatile memory and method with bit line coupled compensation
US7202370B2 (en) * 2003-10-27 2007-04-10 Conor Medsystems, Inc. Semi-synthesis of taxane intermediates from 9-dihydro-13-acetylbaccatin III
HN2005000054A (es) * 2004-02-13 2009-02-18 Florida State University Foundation Inc Taxanos sustituidos con esteres de ciclopentilo en c10
CN1960721A (zh) 2004-03-05 2007-05-09 佛罗里达州立大学研究基金有限公司 C7乳酰氧基取代的紫杉烷类
MX2007009748A (es) * 2005-02-14 2007-09-26 Univ Florida State Res Found Composiciones de taxano sustituidas con esteres ciclopropilicos en c10.
CA2599888C (en) * 2005-03-31 2010-06-15 Bioxel Pharma Inc. Preparation of taxanes from 9-dihydro-13-acetylbaccatin iii
ES2389518T3 (es) 2008-01-18 2012-10-26 Indena S.P.A. Formas sólidas de ortataxel
JP2011517455A (ja) * 2008-03-31 2011-06-09 フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド Ｃ（１０）エチルエステルおよびｃ（１０）シクロプロピルエステル置換タキサン
US8236319B2 (en) 2008-04-30 2012-08-07 Immunogen, Inc. Cross-linkers and their uses
WO2014080251A1 (en) 2012-11-24 2014-05-30 Hangzhou Dac Biotech Co., Ltd. Hydrophilic linkers and their uses for conjugation of drugs to cell binding molecules
ES2960619T3 (es) 2014-02-28 2024-03-05 Hangzhou Dac Biotech Co Ltd Enlazadores cargados y sus usos para la conjugación
CA2991973C (en) 2015-07-12 2021-12-07 Suzhou M-Conj Biotech Co., Ltd. Bridge linkers for conjugation of a cell-binding molecule
US9839687B2 (en) 2015-07-15 2017-12-12 Suzhou M-Conj Biotech Co., Ltd. Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
CN110099682B (zh) 2016-11-14 2023-03-31 杭州多禧生物科技有限公司 偶联连接体，含有此连接体的细胞结合分子-药物偶联物及其制备和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG46582A1 (en) * 1991-09-23 1998-02-20 Univ Florida State 10-Desacetoxytaxol derivatives
US5283253A (en) * 1991-09-23 1994-02-01 Florida State University Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them
US5284865A (en) * 1991-09-23 1994-02-08 Holton Robert A Cyclohexyl substituted taxanes and pharmaceutical compositions containing them
IT1254517B (it) * 1992-03-06 1995-09-25 Indena Spa 14-beta idrossi-10-deacetil-baccatina iii, suoi derivati, loro prepazione ed impiego terapeutico
FR2697752B1 (fr) * 1992-11-10 1995-04-14 Rhone Poulenc Rorer Sa Compositions antitumorales contenant des dérivés du taxane.
ZA94128B (en) * 1993-02-01 1994-08-19 Univ New York State Res Found Process for the preparation of taxane derivatives and betalactam intermediates therefor
US5475011A (en) * 1993-03-26 1995-12-12 The Research Foundation Of State University Of New York Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment
MA23823A1 (fr) * 1995-03-27 1996-10-01 Aventis Pharma Sa Nouveaux taxoides, leur preparation et les compositions qui les contiennent

Also Published As

Publication number Publication date
CA2276483A1 (en) 1998-07-16
ES2196393T3 (es) 2003-12-16
US5811452A (en) 1998-09-22
AU738536B2 (en) 2001-09-20
JP2001509150A (ja) 2001-07-10
DE69720535D1 (de) 2003-05-08
EP0966456B1 (de) 2003-04-02
IL130669A0 (en) 2000-06-01
AU5903798A (en) 1998-08-03
KR20000069887A (ko) 2000-11-25
BR9714272A (pt) 2000-04-18
EP0966456A4 (de) 2000-07-26
EP0966456A1 (de) 1999-12-29
WO1998030553A1 (en) 1998-07-16
DE69720535T2 (de) 2004-03-04

Similar Documents

Publication Publication Date Title
ATE236143T1 (de) Die wirkstoffresistenz in der krebs-chemotherapie umkehrende taxoide mittel und pharmazeutische zubereitungen davon
DE60108154D1 (de) Pharmazeutische Zubereitungen enthaltend Clavulansäure
WO2007059019A3 (en) Novel colored solutions of injectable drugs and their pharmaceutically acceptable salts
ME00017B (me) Derivati kamptotecina koji imaju antitumorno dejstvo
ATE327977T1 (de) Tetrahydrochinolin-derivate als crth2 antagonisten
HUP0104273A2 (hu) Szemiszintetikus ecteinascidinek és ezeket tartalmazó gyógyászati készítmények
GEP20043375B (en) APRIL-Receptor (BCMA) and Use Thereof
DE69323549D1 (de) Topisch anwendbare arzneimittel, enthaltend toremifen und dessen metabolite
HUP0102521A2 (hu) Sztilbénszármazékot és platina koordinációs vegyületet tartalmazó daganatellenes szer
MA28011A1 (fr) Derives de piperazine et leur utilisation en tant qu'agents therapeutiques
HUP0400203A2 (hu) Epotilon analógok és kemoterápiás szerek kombinációja proliferatív betegségek kezelésére alkalmas gyógyszerkészítmény előállítására
ATE429210T1 (de) Orale flüssige zusammensetzungen
WO2001066123A3 (en) Composition consisting of phy906 and chemotherapeutic agents
ES2049690T1 (es) Derivados de taxano, su preparacion y uso en oncologia.
ATE303363T1 (de) 4-aminopyridinderivate, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zusammensetzungen
BR0110837A (pt) Quimioterapia de combinação
DE69215999D1 (de) Therapeutische Mittel für die Behandlungder Resistenz gegen Arzneimittel bei Krebs
AR029509A1 (es) Una composicion farmaceutica en base a un compuesto de platino (iv) y el uso de dicho compuesto para preparar medicamentos antitumorales
BR0001201A (pt) Composto ( poli ) tia-alcinóicos, composição cosmética, utilização de uma composição cosmética, utilização de um composto e composição farmacêutica
TR200402070T4 (tr) Siklobüten-dion türevleri ve bunların damar sertliği tedavisinde kullanımı
FR2754818B1 (fr) Nouveaux derives bi-aromatiques du dibenzofuranne et leur utilisation en medecine humaine ou veterinaire ainsi qu'en cosmetique
BR0206960A (pt) Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose
DE50114335D1 (de) Lh-rh-antagonisten, deren herstellung und verwendung als arzneimittel
AU4558201A (en) Taxane anticancer agents
TR199900013T2 (xx) Yeni bile�ikler.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties